MLL
GWPH

Moody Lynn & Lieberson’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

Moody Lynn & Lieberson’s Portfolio GWPH Stock Details GWPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-4,645
Closed -$648K – 217
2018
Q2 		$648K Buy
+4,645
New +$660K 0.08% 130

Other funds holding GWPH

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
SCM
Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return
PP
Prudential plc London, England, United Kingdom $17.1B AUM 15.7% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Moody Lynn & Lieberson's GWPH Position: Q3 2018 in Review

Moody Lynn & Lieberson sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q3 2018, closing a stake of 4,645 shares — an estimated $648K sold.

Moody Lynn & Lieberson first reported a position in GWPH in Q2 2018 and held it in 1 quarter. The position peaked at $648K in Q2 2018. 272 funds tracked by Wall St. Rank hold GWPH as of Q3 2018.

  • Moody Lynn & Lieberson reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q3 2018 after selling out during the quarter.
  • Moody Lynn & Lieberson sold 4,645 GW Pharmaceuticals Plc American Depositary Shares shares in Q3 2018, an estimated $648K.
  • Moody Lynn & Lieberson first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q2 2018 and held it in 1 quarter.
  • Moody Lynn & Lieberson's GW Pharmaceuticals Plc American Depositary Shares position peaked at $648K in Q2 2018.
  • 272 funds tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q3 2018.

Based on Moody Lynn & Lieberson's 13F filing for Q3 2018, filed 29 Oct 2018.